Kossoy, G., et al., Epitalon and colon carcinogenesis in rats: Proliferative activity and apoptosis in colon tumors and mucosa
Seiwerth and colleagues (Inflammopharmacology, 1999) documented effects on angiogenic growth factor pathway signalling, and subsequent work has expanded characterisation to include VEGF receptor 2 upregulation, endothelial cell migration in capillary-formation assays, and improved healing in ischemia-reperfusion preparations
This usually involves a dose of one to two milligrams given subcutaneously daily for ten to 21 days, repeated as needed based on her results

Key Features Blend strength: BPC-157 10 mg + TB-500 10 mg per vial (20 mg total) Pack size: 10 vials/kit (bulk supply available on request) Format: lyophilized powder for stable storage and handling in lab workflows Supplier positioning: China-based factory supply with export-ready cartons and secure packing Documentation: batch labeling and order coordination support for repeat wholesale buyers Typical Research Focuses Recovery-support and tissue-repair pathway models (non-clinical, research settings) Mobility & training-load recovery study frameworks (protocol-based, lab handling required) Stack compatibility research and stability handling for lyophilized peptide formats General peptide handling, storage, and logistics workflows for distributors Packaging & Ordering Standard inner packing: 10-vial plastic trays with bubble wrap and foam protection Outer packing: export-ready cartons with insulation and protective materials suitable for international transit Flexible order quantities starting from 1 kit for sample evaluation
